🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Regression begins when you reach LDLc < 70 mg/dL (note that in the Nissen’s article the mean LDLc was > 94 mg/dL)

A masterpiece by Maciej Banach & colleagues of only 2-pages of which every line must be read. IF YOU FOLLOW ME - PROMISE TO READ ASAP - The paper so succinctly refutes every denier statement ever made. Free download ow.ly/tLjO50Pc8GN National Lipid Association academic.oup.com/eurheartj/adva…

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease #AHAJournals ahajournals.org/doi/10.1161/CI…

A good opportunity to remind researchers that unadjusted Kaplan-Meier survival curves are mixtures of survival time distributions with strange weights, due to within-treatment variation of patient characteristics. #Statistics #clinicalresearch @vandy_biostat @EdgeforScholars

Latest JACC Journals: The Evolving Role of Cardiac Troponin: From Acute to Chronic Coronary Syndromes bit.ly/456vHNc. Our editorial addressing the research by Ryan Wereski Nicholas Mills et al. on hs #troponin for risk assessment in chronic CAD bit.ly/3QjSq3W

In patients with chronic CAD, an elevated #troponin identifies those more likely to have MI or CV death. Routine troponin testing in this setting could inform patient selection for additional treatment. bit.ly/3rZhhjp #JACC #cvCAD #CardioTwitter #cvPrev #cvMI

The goal of the STOP-CA trial was to assess whether concomitant treatment w/ atorvastatin may prevent the reduction in LVEF that may be seen in patients w/ lymphoma receiving anthracycline-based chemotherapy. Get the trial details here ➡️ bit.ly/440Xu0n #CardioOnc

Bringing up the rear of team Edinburgh, finally en route to #ESC2023 with Ryan Wereski after an honest morning’s work and an honest evening’s gin and tonic tasting 🍸 Tot snel Amsterdam and my wonderful cardiology friends 🤩 🌷 🇳🇱 European Society of Cardiology European Society of Cardiology Journals

“Risk prediction by machines”. Excellent presentation by Andrew Chapman at European Society of Cardiology #Amsterdam

“Pre-operative cardiovascular risk assessment allows patients to make an informed choice about proposed surgery” European Society of Cardiology Abbott

“Biomarkers do not replace clinical judgement and we must think: What is the biomarker telling me in the setting in which it was measured” @JJheart_doc European Society of Cardiology Abbott

Great Debate 🤜 🤛 European Society of Cardiology Pros and Cons of the Universal Definition of Myocardial Infarction at #ESC2023 Excellent summary of the benefits and challenges when using the UDMI in practice 🏥

Additive antithrombotic effects of PAR4 antagonism in patients with coronary artery disease receiving single or dual antiplatelet therapies Nicholas Mills Samuel Debono Jennifer Nash ahajrnls.org/3Tg6LiZ

If PCI as a "therapy" for stable ischemic heart disease is controversial, its role as a "prevention" for vulnerable plaques is even more controversial. In a few weeks, at ACC.24, the PREVENT investigators will present the results of a multicenter, open-label, randomized

"What is a normal cholesterol?" As a cardiologist, I get this question all the time. Most people are getting this all wrong. 📕Make Sure To Bookmark✅ 🧵👇 /1

A new and important paper from JACC on EPA and Lp(a) from REDUCE-IT. Baseline Lp(a) was highly predictive of events in people with high TG and controlled LDL-C, and risk was linear, not threshold. EPA was a/w benefit irrespective of Lp(a) levels. Expands data to people with high

In ORBITA-STAR, angina verification with an ischaemic stimulus powerfully predicted response to PCI. #EuroPCR2024 Perhaps we have been too focused on treatment when the problem always lay in the diagnosis! Published today in #JACC jacc.org/doi/10.1016/j.… Rasha Al-Lamee

Hand-held echocardiography can play an important role in patients hospitalised with acute coronary syndrome! Big thank you to all co-authors for making this happen Shruti Joshi Russell Everett Mikołaj Buchwald Hatem Soliman, FRCP, FEACVI, FASE, FHEA Cosyns Bernard academic.oup.com/ehjcimaging/ad…